Xebio Holdings recorded an extraordinary loss of 7,373 million yen for the fiscal year ending March 2026 and revised the full-year net income forecast to a 2,141 million yen loss.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8281","jir_company_name":"Xebio Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/8281-20260501-01.pdf","jir_short_summary":"Xebio Holdings recorded an extraordinary loss of 7,373 million yen for the fiscal year ending March 2026 and revised the full-year net income forecast to a 2,141 million yen loss.","jir_summary":"### Regarding Booking of Extraordinary Loss\nIn the fourth quarter of the fiscal year ending March 2026, impairment losses of 3,610 million yen will be recorded on domestic and overseas business assets with reduced profitability, along with valuation losses on investment securities of 751 million yen, and a loss on sale of overdue claims of 296 million yen. Additionally, including a fixed asset retirement loss of 2,370 million yen due to renovation and donation of the Xebio Arena Sendai building, a total extraordinary loss of 7,373 million yen is expected.\n\n### Revision of Full-Year Earnings Forecast\nFor the fiscal year ending March 2026, consolidated net sales are revised to 252,377 million yen (down 0.46% from previous forecast), operating income to 2,386 million yen (down 40.60%), ordinary income to 4,669 million yen (down 8.13%), and net income attributable to owners of parent is revised to a loss of 2,141 million yen. While some strength was maintained in the domestic retail business, seasonal products and apparel segments were sluggish due to effects such as a warm winter. On the profit side, decreases in gross profit margin, valuation losses, increased e-commerce system-related expenses, and rises in labor and store expenses negatively impacted results.\n\n### Regarding Reduction of Executives\u2019 Compensation\nTo clarify management responsibility associated with this earnings forecast revision and the booking of extraordinary losses, a measure will be implemented to reduce directors\u2019 monthly compensation by up to 50% for three months, and executive officers\u2019 monthly compensation by up to 30% for three months.","jir_financial_highlights":"Extraordinary Loss: 7,373 million yen (Unknown)\nConsolidated Net Sales: 252,377 million yen (Down 0.46% from previous forecast)\nConsolidated Operating Income: 2,386 million yen (Down 40.60% from previous forecast)\nConsolidated Ordinary Income: 4,669 million yen (Down 8.13% from previous forecast)\nNet Income Attributable to Owners of Parent: Loss of 2,141 million yen (Significant decrease from previous forecast)","jir_category":"","jir_hashtags":"#XebioHoldings, #EarningsForecastRevision, #JapaneseStocks","jir_key_figures":"Total Extraordinary Loss: 7,373 million yen\nConsolidated Net Sales (Revised Forecast): 252,377 million yen (down 0.46% from previous forecast)\nNet Income Attributable to Owners of Parent (Revised Forecast): Loss of 2,141 million yen","jir_meta_title":"Xebio Holdings Revises Down Earnings Forecast for Fiscal Year Ending March 2026\uff5cRecords Extraordinary Loss of 7,373 Million Yen","jir_meta_description":"Xebio Holdings recorded an extraordinary loss of 7,373 million yen in the fiscal year ending March 2026 and revised the full-year net income forecast to a loss. Seasonal products weakened due to a warm winter, and executive compensation reductions were also implemented.","jir_og_title":"Xebio Holdings Revises Down Earnings Forecast for Fiscal Year Ending March 2026\uff5cBooking of Extraordinary Loss","jir_og_description":"Xebio Holdings announced an extraordinary loss of 7,373 million yen and a substantial downward revision of the full-year net income forecast. Seasonal products were weak due to the warm winter.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17366,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-44854","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n